Anticoagulation Treatment Overdose

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anticoagulation Treatment Overdose trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06692504

Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department

Rationale: According to the latest National Survey on Care-Related Adverse Events, anticoagulants, including vitamin K antagonists (VKAs), rank first among med…

France2,080 participantsStarted 2021-01-01

All recent trials (5 shown)

UnknownNot Applicable

NCT03261284

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

This was a prospective, cohort study.

China300 participantsStarted 2019-03-01

Treatment: D-dimer-guided adjustment stratege, Thepeautic-heparin therapy

UnknownNot Applicable

NCT05422170

HEParin Antagonisation in Transcatheter Aortic Valve Implantation

Unfractioned heparin is usually given in a defined dosage during transfemoral TAVI. Activated Clotting Time (ACT) is usually used to measure the heparin effect.…

Germany50 participantsStarted 2022-07-01

UnknownNot Applicable

NCT01633957

Anticoagulation Treatment Overdose

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department

All recent trials (5 shown)

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

HEParin Antagonisation in Transcatheter Aortic Valve Implantation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department

All recent trials (5 shown)

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

HEParin Antagonisation in Transcatheter Aortic Valve Implantation

A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve

To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic